Many mini setbacks

Theranos halts new Zika test after FDA inspection concludes a company study didn’t include proper patient safeguards to ensure patients are treated safely and ethically during medical studies. And if that wasn’t enough, the University of Washington refused to do research with the firm, calling it a “disgraced” company. Heard that before.